Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $23.2600 (-2%) ($23.2600 - $23.2600) on Thu. Jul. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.5% (three month average) | RSI | 31 | Latest Price | $23.2600(-2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.6% a day on average for past five trading days. | Weekly Trend | IOVA declines -5.1% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(45%) XBI(42%) IWO(41%) ARKG(40%) IWC(39%) | Factors Impacting IOVA price | IOVA will decline at least -3.25% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-11%) TBT(-5%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.25% (StdDev 6.5%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $12.33(-46.99%) | Resistance Level | $24.94 | 5 Day Moving Average | $23.25(0.04%) | 10 Day Moving Average | $23.84(-2.43%) | 20 Day Moving Average | $24.94(-6.74%) | To recent high | -29.6% | To recent low | 43.9% | Market Cap | $3.406b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |